Status:

COMPLETED

Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults

Lead Sponsor:

Tongji Hospital

Conditions:

Hypotension During Surgery

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

Research objective: To explore the safety and dose exploration of Remimazolam Tosilate for Injection for induction and maintenance of general anesthesia in elective short-term surgery in adults. Main...

Detailed Description

The data collected in this study is recorded by the researcher in the eCRF, including: 1. Data to be collected during the screening period and before the operation: the basic characteristics of the p...

Eligibility Criteria

Inclusion

  • ASA Ⅰ-Ⅲ grade;
  • age 18-65 years old;
  • gender is not limited;
  • planned elective support laryngoscope surgery (glottic polypectomy under support laryngoscope, epiglottic cyst excision under support laryngoscope, benign laryngeal under support laryngoscope Lesion resection), endoscopic septoplasty, endoscopic tympanoplasty, endoscopic middle ear tube insertion, nasopharyngoplasty, head and neck benign mass resection for general anesthesia intubation patients;
  • operation time No more than 90min.

Exclusion

  • \- Emergency surgery;
  • abnormal renal function (urea nitrogen ≥1.5×ULN, blood creatinine greater than the upper limit of normal);
  • abnormal liver function;
  • hypovolemia, shock or coma;
  • suffering from mental illness and long-term use of psychotropic drugs;
  • cognition Dysfunction;
  • those who are allergic to or contraindicated to benzodiazepines and their drug components; pregnant or lactating female patients;
  • have a history of drug dependence;
  • have used other sedatives in the past week;
  • have been a subject within the past 3 months Participated in drug clinical trials

Key Trial Info

Start Date :

July 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2025

Estimated Enrollment :

650 Patients enrolled

Trial Details

Trial ID

NCT04908553

Start Date

July 1 2021

End Date

May 31 2025

Last Update

June 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

TongjiHospital

Wuhan, China

Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults | DecenTrialz